Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
American Heart Journal
|
February 5, 2004
Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes
Darren K McGuire, L Kristin Newby, Manjushri V Bhapkar, et al.
Circulation
|
May 16, 2007
Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology
Karen P Alexander, L Kristin Newby, Christopher P Cannon, et al.
Circulation
|
May 16, 2007
Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology
Karen P Alexander, L Kristin Newby, Paul W Armstrong, et al.
JACC. Cardiovascular Interventions
|
August 24, 2013
Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: results from 1,208,137 procedures in the NCDR (National Cardiovascular Data Registry)
J Matthew Brennan, Jeptha P Curtis, David Dai, et al.
Circulation
|
March 20, 2016
Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy Study
Ian T Meredith, Jean-François Tanguay, Dean J Kereiakes, et al.
The American Journal of Cardiology
|
June 14, 2005
Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes
Kenneth W Mahaffey, Matthew T Roe, Rakhi Kilaru, et al.
Circulation
|
November 23, 2005
Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT)
Harvey D White, Philip E G Aylward, Zhen Huang, et al.
The American Journal of Cardiology
|
July 10, 2016
Relation of Left Ventricular Mass and Infarct Size in Anterior Wall ST-Segment Elevation Acute Myocardial Infarction (from the EMBRACE STEMI Clinical Trial)
Yazan Daaboul, Serge Korjian, W Douglas Weaver, et al.
European Heart Journal
|
November 4, 2004
An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry
Eric J Velazquez, Gary S Francis, Paul W Armstrong, et al.
JAMA
|
September 1, 2014
Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial
Michelle L O'Donoghue, Eugene Braunwald, Harvey D White, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
American Heart Journal
|
February 5, 2004
Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes
Darren K McGuire, L Kristin Newby, Manjushri V Bhapkar, et al.
Circulation
|
May 16, 2007
Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology
Karen P Alexander, L Kristin Newby, Christopher P Cannon, et al.
Circulation
|
May 16, 2007
Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology
Karen P Alexander, L Kristin Newby, Paul W Armstrong, et al.
JACC. Cardiovascular Interventions
|
August 24, 2013
Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: results from 1,208,137 procedures in the NCDR (National Cardiovascular Data Registry)
J Matthew Brennan, Jeptha P Curtis, David Dai, et al.
Circulation
|
March 20, 2016
Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy Study
Ian T Meredith, Jean-François Tanguay, Dean J Kereiakes, et al.
The American Journal of Cardiology
|
June 14, 2005
Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes
Kenneth W Mahaffey, Matthew T Roe, Rakhi Kilaru, et al.
Circulation
|
November 23, 2005
Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT)
Harvey D White, Philip E G Aylward, Zhen Huang, et al.
The American Journal of Cardiology
|
July 10, 2016
Relation of Left Ventricular Mass and Infarct Size in Anterior Wall ST-Segment Elevation Acute Myocardial Infarction (from the EMBRACE STEMI Clinical Trial)
Yazan Daaboul, Serge Korjian, W Douglas Weaver, et al.
European Heart Journal
|
November 4, 2004
An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry
Eric J Velazquez, Gary S Francis, Paul W Armstrong, et al.
JAMA
|
September 1, 2014
Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial
Michelle L O'Donoghue, Eugene Braunwald, Harvey D White, et al.
Page
of 9